STME (Stimcell Energetics) 5-Year RORE % : -54.99% (As of Feb. 2026)


STME Stimcell Energetics Inc STME
25 GF Score
Price $0.31
! 4 Warning Signs
View Full Analysis

What is Stimcell Energetics 5-Year RORE %?

Stimcell Energetics STME 25 5-Year RORE % is -54.99 as of Feb. 2026. GuruFocus rates STME with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 706 Medical Devices & Instruments companies, Stimcell Energetics ranks worse than 86.26% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Stimcell Energetics's 5-Year RORE % for the quarter that ended in Feb. 2026 was -54.99%.

The industry rank for Stimcell Energetics's 5-Year RORE % or its related term are showing as below:

STME's 5-Year RORE % is ranked worse than
86.26% of 706 companies
in the Medical Devices & Instruments industry
Industry Median: -5.13 vs STME: -54.99

Stimcell Energetics  (OTCPK:STME) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Stimcell Energetics 5-Year RORE % Related Terms


Stimcell Energetics 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for Stimcell Energetics's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stimcell Energetics 5-Year RORE % Chart

Stimcell Energetics Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.99 -28.53 -18.54 -42.73 -46.10

Stimcell Energetics Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.16 -46.10 -48.88 -51.41 -54.99

STME vs NVNO, TRIB, AIDX: 5-Year RORE % Comparison

For the Medical Devices subindustry, Stimcell Energetics's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stimcell Energetics 5-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stimcell Energetics's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Stimcell Energetics's 5-Year RORE % falls into.


STME
25GF Score
Stimcell Energetics Inc STME
5-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stimcell Energetics 5-Year RORE % Calculation

Stimcell Energetics's 5-Year RORE % for the quarter that ended in Feb. 2026 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -0.03--0.278 )/( -0.451-0 )
=0.248/-0.451
=-54.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Feb. 2026 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of -54.99 mean?
Stimcell Energetics (STME) has a 5-Year RORE % of -54.99 as of Feb. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Stimcell Energetics and its competitors. According to the industry distribution chart, Stimcell Energetics ranks #609 out of 706 companies in the Medical Devices & Instruments industry, placing it in the top 86.3%.
Is Stimcell Energetics' 5-Year RORE % too high?
Stimcell Energetics' current 5-Year RORE % is -54.99. Based on the distribution chart, Stimcell Energetics ranks #609 out of 706 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Stimcell Energetics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Stimcell Energetics' 5-Year RORE % compare to NVNO and TRIB?
According to the Medical Devices & Instruments industry distribution chart, Stimcell Energetics ranks #609 out of 706 companies for 5-Year RORE %. This places Stimcell Energetics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Medical Devices & Instruments company?
A good 5-Year RORE % depends on the Medical Devices & Instruments industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Stimcell Energetics and its competitors. Stimcell Energetics's current 5-Year RORE % is -54.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stimcell Energetics stock overvalued right now?
Stimcell Energetics (STME) has a current 5-Year RORE % of -54.99. The current 5-Year RORE % is -54.99. Stimcell Energetics' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Stimcell Energetics (STME), the current 5-Year RORE % is -54.99 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stimcell Energetics Business Description

Address 1130 Pender Street, West, Suite 820, Vancouver, BC, CAN, V6E 4A4
Stimcell Energetics Inc is a biotech company focused on the discovery, development, and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness, and alleviate health complications, including, but not limited to: aging, diabetes, high blood pressure, neuropathy, and kidney function. The company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System.
25GF Score

Get the complete analysis for STME

5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price